Publication | Closed Access

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

AntibioticsCeftazidime-avibactam Versus MeropenemRespiratory InfectionInfectious Respiratory DiseaseNon-inferiority TrialMedicineClinical MicrobiologyPhase 3